DTPX Therapeutics and Azane Therapeutics are the top teams at the Building a Biotech Venture Pitch Competition
Research grants awarded to products that could impact cancer and rare genetic diseases.
Medicine by Design-funded research uncovers method of stratifying cancer cells
Research reveals a potential way to tailor acute myeloid leukemia (AML) therapies to individual patients.
Six teams to compete for two grants at Medicine by Design’s Building a Biotech Venture Pitch Competition, $25,000 or $10,000
Trainee-led teams will pitch their ideas in front of expert judges for the chance to receive one of two research funding grants.
Several Medicine by Design-funded projects to be further advanced by Stem Cell Network investment
The Medicine by Design-funded researchers awarded come from disciplines that include stem cell biology, neuroscience and biomedical engineering.
New Medicine by Design-funded research illuminates the role of a little-understood immune cell
New research sheds light on the role of monocytes.
New Medicine by Design-funded research shows lab-made endothelial cells may be able treat liver diseases including hemophilia A
New research is a step forward to cell therapies for liver disease
Medicine by Design partners with Temerty Faculty of Medicine’s RASI to fund summer students from underrepresented communities
Program to fully fund summer positions in Medicine by Design labs beginning in summer 2022.
Two multi-disciplinary research teams awarded Catalyst Grants co-sponsored by Medicine by Design and the Data Sciences Institute
Catalyst Grants co-awarded to research projects that hold promise in strengthening the connection between data science innovation and regenerative medicine.
New Medicine by Design-supported research shows mature heart cells perform well in transplants
Study is an important step forward in researchers’ understanding of treating damaged hearts with cell therapies.
Medicine by Design announces two new Pivotal Experiment Fund projects
Projects to impact autoimmune, intestinal and degenerative eye diseases
New Medicine by Design-funded research advances an under-skin cell therapy for type 1 diabetes
Research shows that transplanted pancreatic cells were able to survive in animal hosts.
Medicine by Design symposium panel explores strategies for strengthening Canada’s bioinnovation ecosystem
Themes like lessons learned from COVID-19, symbiotic partnerships and access to risk capital emerge in wide-ranging discussion.
Enabling long-lasting cell therapy for diabetes without injection
Is immunoengineering the key to ensuring that cell therapies can treat disease?
Medicine by Design symposium to celebrate systems approaches in advancing regenerative medicine and health innovation
The 6th Annual Symposium on Dec. 9 and 10 will feature renowned experts to explore cutting-edge concepts in health research and innovation.
Medicine by Design-funded researchers generate cells that will impact treatments for bile duct disorders as a result of cystic fibrosis
Newly-generated cells may lead to a deeper understanding of bile duct disease and be a powerful tool for finding new treatments.